References Evidence grades A (strongest) to D (editorial or working analysis)
I struggled with inconsistent results, constipation, dizziness, confusion about dosing, and uncertainty about exactly what I had purchased
The available GLP-1 RA injectables are short or long-acting, and include [5,8-14]: Dulaglutide: Long-acting, once weekly Exenatide: Short-acting, twice a day Exenatide extended release: Long-acting, once weekly Liraglutide: Long-acting, once a day Lixisenatide: Short-acting, once a day Semaglutide: Long-acting, once weekly Combination of GLP-1 medications and exercise Non-medication management strategies for type 2 diabetes involve lifestyle modifications like diet and exercise
(PubMed) The problem is not that these theories are unreasonable
Limited studies show no possible dose adjustments
Griffin, S